FDA Inspection 1088285 — Haupt Pharma Wuelfing GmbH
The FDA completed an inspection of Haupt Pharma Wuelfing GmbH on December 7, 2018 in Gronau (Leine). The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 7, 2018
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Gronau (Leine) (Germany)